Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel

International Journal of Biological Macromolecules

Volumn 80, Issue , 2015, Pages 29-40

  Emami, Jaber ^a   Rezazadeh, Mahboubeh ^a   Hasanzadeh, Farshid ^a   Sadeghi, Hojjat ^a   Mostafavi, Abolfazl ^a   Minaiyan, Mohsen ^a   Rostami, Mahboubeh ^a   Davies, Neal ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Paclitaxel; Pharmacokinetics; Polymeric micelle

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; CHITOSAN; CREMOPHOR; FOLIC ACID; MACROGOL; PACLITAXEL; ANTINEOPLASTIC AGENT; DRUG CARRIER; MICELLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CANCER CHEMOTHERAPY; CELL SIZE; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; TISSUE DISTRIBUTION; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CHEMISTRY; DRUG SCREENING; HALF LIFE TIME; HUMAN; MCF 7 CELL LINE;

MUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG CARRIERS; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG STABILITY; FEMALE; HALF-LIFE; HUMANS; MCF-7 CELLS; MICE, INBRED BALB C; MICELLES; NEOPLASM TRANSPLANTATION; PACLITAXEL; PARTICLE SIZE; TISSUE DISTRIBUTION;

EID: 84934906621     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2015.05.062     Document Type: Article

References (35)

1. Yao Z., Zhang C., Ping Q., Yu L. A series of novel chitosan derivatives: synthesis, characterization and micellar solubilization of paclitaxel. Carbohydr. Polym. 2007, 68:781-792.
2. Qu G., Yao Z., Zhang C., Wu X., Ping Q. PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation. Eur. J. Pharm. Sci. 2009, 37:98-105.
3. Hwang H.Y., Kim I.S., Kwon I.C., Kim Y.H. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J. Control. Release 2012, 128:23-31.
4. Nishiyama N., Morimoto Y., Jang W.D., Kataoka K. Design and development of dendrimer photosensitizer-incorporated polymeric micelles for enhanced photodynamic therapy. Adv. Drug Deliv. Rev. 2009, 61:327-338.
5. Trubetskoy V.S. Polymeric micelles as carriers of diagnostic agents. Adv. Drug Deliv. Rev. 1999, 37:81-88.
6. Shin H.C., Alani W.G., Rao D.A., Rockich N.C., Kwon G.S. Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs. J. Control. Release 2009, 140:294-300.
7. Xiao H., Li W., Qi R., Yan L., Wang R., Liu S.H., Zhang Y., Xie Z., Huang Y., Jing X. Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy. J. Control. Release 2012, 163:304-314.
8. Qu D., Lin H., Zhang N., Xue J., Zhang C. In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery. Carbohydr. Polym. 2013, 92:545-554.
9. Hu F.Q., Ren G.F., Yuan H., Du Y.Z., Zeng S. Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. Colloids Surf. B: Biointerfaces 2006, 50:97-103.
10. Ngawhirunpat T., Wonglertnirant N., Opanasopit P., Ruktanonchai U., Yoksan R., Wasanasuk K., Chirachanchai S. Incorporation methods for cholic acid chitosan-g-mPEG self-assembly micellar system containing camptothecin. Colloids Surf. B: Biointerfaces 2009, 74:253-259.
11. Du Y.Z., Wang L., Yuan H., Hu F.Q. Linoleic acid-grafted chitosan oligosaccharide micelles for intracellular drug delivery and reverse drug resistance of tumor cells. Int. J. Biol. Macromol. 2011, 48:215-222.
12. Lee K.Y., Kim H.J., Kwon I.C., Jeong S.Y. Self-aggregates of deoxycholic acid-modified chitosan as a novel carrier of Adriamycin. Colloid Polym. Sci. 2000, 278:1216-1219.
13. Zhang X., Jackson J.K., Burt H.M. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int. J. Pharm. 1996, 132:195-206.
14. Kim S.C., Kim D.W., Shim Y.H., Bang J.S., Oh H.S., Seo M.H. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J. Control. Release 2001, 72:191-202.
15. Hu F.Q., Meng P., Dai Y.Q., Du Y.Z., You J., Wei X.H., Yuan H. PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy. Eur. J. Pharm. Biopharm. 2008, 70:749-775.
16. Liu J., Li H., Chen D., Jin X., Zhao X., Zhang C., Ping Q. In vivo evaluation of novel chitosan graft polymeric micelles for delivery of paclitaxel. Drug Deliv. 2011, 18:181-189.
17. Liu J., Zeng F., Allen C. In vivo fate of unimers and micelles of a poly (ethylene glycol)-block-poly (caprolactone) copolymer in mice following intravenous administration. Eur. J. Pharm. Biopharm. 2007, 65:309-319.
18. Yang C., Attia A., Tan P.K., Ke X., Gao S., Hedrick J., Yang Y. The role of non-covalent interactions in anticancer drug loading and kinetic stability of polymeric micelles. Biomaterials 2012, 33:2971-2979.
19. Wang F., Chen Y., Zhang D., Zhang Q., Zheng D., Hao L., Liu Y. Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid micelles. Int. J. Nanomed. 2012, 7:325-337.
20. Hami Z., Amini M., Ghazi-Khansari M., Rezayat M., Gilani K. Synthesis and in vitro evaluation of a pH-sensitive PLA-PEG-folate based polymeric micelle for controlled delivery of docetaxel. Colloids Surf. B: Biointerfaces 2014, 116:309-317.
21. Wu D.Q., Lu B., Chang C., Chen C.S., Wang T., Zhang Y.Y. Galactosylated fluorescent labeled micelles as a liver targeting drug carrier. Biomaterials 2009, 30:1363-1371.
22. Nam J.P., Park S.C., Kim T.H., Jang J.Y., Choi C., Jang M.K., Nah J.W. Encapsulation of paclitaxel into lauric acid-O-carboxymethyl chitosan-transferrin micelles for hydrophobic drug delivery and site-specific targeted delivery. Int. J. Pharm. 2013, 457:124-135.
23. Maya S., Kumar L.G., Sarmento B., Rejinold N.S., Menon D., Nair Sh., Jayakumar R. Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells. Carbohydr. Polym. 2013, 93:661-669.
24. Emami J., Rezazadeh M., Rostami M., Hsanzadeh F., Sadeghi H., Mostafavi A., Minaiyan M., Lavasanifar F. Co-delivery of paclitaxel and α-tocopherol succinate by novel chitosan-based polymeric micelles for improving micellar stability and efficacious combination therapy. Drug Dev. Ind. Pharm. 2014, (in press). 10.3109/03639045.2014.935390.
25. Morris V.B., Sharma C.P. Folate mediated in vitro targeting of depolymerised trimethylated chitosan having arginine functionality. J. Colloid Interface Sci. 2010, 348:360-368.
26. Zhang Y., Huo M., Zhou J., Yu D., Wu Y. Potential of amphiphilically modified low molecular weight chitosan as a novel carrier for hydrophobic anticancer drug: Synthesis, characterization, micellization and cytotoxicity evaluation. Carbohydr. Polym. 2009, 77:231-238.
27. Attia A., Yang C., Tan J., Gao S., Williams D., Hedrick J., Yang Y. The effect of kinetic stability on biodistribution and anti-tumor efficacy of drug-loaded biodegradable polymeric micelles. Biomaterials 2013, 34:3132-3140.
28. Emami J., Rezazadeh M., Varshosaz J., Tabbakhian M., Aslani A. Formulation of LDL targeted nanostructured lipid carriers loaded with paclitaxel: a detailed study of preparation, freeze drying condition, and in vitro cytotoxicity. J. Nanomater. 2012, 10.1155/2012/358782.
29. Du Y.Z., Wang L., Yuan H., Wei X.H., Hu F.Q. Preparation and characteristics of linoleic acid-grafted chitosan oligosaccharide micelles as a carrier for doxorubicin. Colloids Surf. B: Biointerfaces 2009, 69:257-263.
30. Lu Y., Park K. Polymeric micelles and alternative nanosized delivery vehicles for poorly soluble drugs. Int. J. Pharm. 2013, 453:198-214.
31. Seow W., Xue J., Yang Y. Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles. Biomaterials 2007, 1730-1740.
32. Zhang W., Shi Y., Chen Y., Ye J., Sha X., Fanga X. Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials 2011, 32:2894-2906.
33. Liang N., Sun S., Li X., Pia H., Cui F., Fang L. α-Tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: preparation, characterization and in vitro/in vivo evaluations. Int. J. Pharm. 2012, 423:480-488.
34. Yuan H., Miao J., Du Y.Z., You J., Hu F.Q., Zeng S. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int. J. Pharm. 2008, 348:137-145.
35. Xin H.L., Chen L.C., Gu J.J., Ren X.Q., Wei Z., Luo J.Q., Chen Y.Z., Jiang X.Y., Sha X.Y., Fang X.L. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(e{open}-caprolactone) nanoparticles: in vitro and in vivo evaluation. Int. J. Pharm. 2010, 402:238-247.